Healthcare DIVE June 30, 2023
Dive Brief:
- The U.S. Food and Drug Administration is asking for public input on the transition to at-home care and how regulators can support enabling technologies.
- As part of its push to advance health equity, the FDA has posed a series of home-care questions to the medtech industry, including a query about how it can support the development of devices for use in non-clinical care settings.
- Other questions cover how digital health technologies can support home-based healthcare, the device design attributes that facilitate use outside of clinical settings and methods for generating data to inform regulatory reviews.
Dive Insight:
The development of remote patient-monitoring devices and other connected medical technologies has made it possible to treat more patients...